These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15719978)

  • 1. Dose perturbation of a novel cobalt chromium coronary stent on 32P intravascular brachytherapy: a monte carlo study.
    Mourtada F; Horton JL
    Med Phys; 2005 Jan; 32(1):268-74. PubMed ID: 15719978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculations of dose distributions around 32P and 198Au stents for intravascular brachytherapy.
    Reynaert N; Verhaegen F; Taeymans Y; Van Eijkeren M; Thierens H
    Med Phys; 1999 Aug; 26(8):1484-91. PubMed ID: 10501047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte carlo parametric study of stent impact on dose for catheter-based intravascular brachytherapy with 90Sr/90Y.
    Ortego PM; Prieto C; Vano E
    Med Phys; 2004 Jul; 31(7):1964-71. PubMed ID: 15305447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose effects of stents in intravascular brachytherapy for in-stent restenosis: a Monte Carlo calculation.
    Li XA
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):842-8. PubMed ID: 12573772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-absorption correction for 32P, 198Au and 188Re stents: dose point kernel calculations versus Monte Carlo.
    Reynaert N; Häfeli UO
    Med Phys; 2001 Sep; 28(9):1883-97. PubMed ID: 11585219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta versus gamma for catheter-based intravascular brachytherapy: dosimetric perspectives in the presence of metallic stents and calcified plaques.
    Li XA; Wang R; Yu C; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1043-9. PubMed ID: 10705028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia.
    Milewski K; Zurakowski A; Pajak J; Pajak-Zielinska E; Liszka L; Buszman PP; Bis J; Debinski M; Buszman PE
    Med Sci Monit; 2010 Jan; 16(1):BR40-4. PubMed ID: 20037484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry study for beta-radiation treatment of in-stent restenosis.
    Chu CH; Hsieh BT; Chen IJ; Chen WL; Lin UT
    Radiat Prot Dosimetry; 2009 Feb; 134(1):49-54. PubMed ID: 19376885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of stent on radiation dosimetry in an in-stent restenosis model.
    Fan P; Chiu-Tsao ST; Patel NS; Shih A; Ravi K; Sherman W; Tsao HS; Pisch J; Harrison LB
    Cardiovasc Radiat Med; 2000; 2(1):18-25. PubMed ID: 11229057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo Dosimetry of the 60Co BEBIG High Dose Rate for Brachytherapy.
    Campos LT; de Almeida CE
    PLoS One; 2015; 10(9):e0139032. PubMed ID: 26418559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of imaging-derived parameters to dosimetry of intravascular brachytherapy sources: perturbation effects of residual plaque burden.
    Sehgal V; Li Z; Palta JR; Smith KM; Bolch WE
    Med Phys; 2002 Jul; 29(7):1580-9. PubMed ID: 12148741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A segmented 32P source Monte Carlo model to derive AAPM TG-60 dosimetric parameters used for intravascular brachytherapy.
    Mourtada F; Soares CG; Horton JL
    Med Phys; 2004 Mar; 31(3):602-8. PubMed ID: 15070260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose perturbation caused by stents: experiments with a model 90Sr/90Y source.
    Wilczek K; Petelenz B; Strzała A; Marczewska B; Traczyk M; Poloński L
    Cardiovasc Intervent Radiol; 2007; 30(5):981-91. PubMed ID: 17710473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving patient-specific dosimetry for intravascular brachytherapy.
    Li XA; O'Neill M; Suntharalingam M
    Brachytherapy; 2005; 4(4):291-7. PubMed ID: 16344260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real world experience with an indigenously manufactured stent Cobal C--a retrospective study.
    Sastry BK; Kumar N; Menon R; Kapadia A; Sridevi C; Surya Prakash G; Krishna Reddy N; Srinivasa Rao M
    Indian Heart J; 2014; 66(5):525-9. PubMed ID: 25443606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of different stent alloys on human vascular response to everolimus-eluting stent: an optical coherence tomography study: the OCTEVEREST.
    Guagliumi G; Capodanno D; Ikejima H; Bezerra HG; Sirbu V; Musumeci G; Fiocca L; Lortkipanidze N; Vassileva A; Tahara S; Valsecchi O; Costa MA
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):510-8. PubMed ID: 22431208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.
    Park KW; Kang SH; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Hur SH; Ryu JK; Lee BR; Park YW; Chae IH; Kim HS;
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2805-16. PubMed ID: 24814486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion.
    He Y; Maehara A; Mintz GS; Bharaj H; Castellanos C; Kesanakurthy S; Wu X; Guo N; Choi SY; Leon MB; Stone GW; Mehran R; Rabbani LE; Moses JW
    Am J Cardiol; 2010 May; 105(9):1272-5. PubMed ID: 20403478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new delivery system to resolve dosimetric issues in intravascular brachytherapy.
    DeCunha JM; Enger SA
    Brachytherapy; 2018; 17(3):634-643. PubMed ID: 29519606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platinum chromium element stent platform: from alloy, to design, to clinical practice.
    Menown IB; Noad R; Garcia EJ; Meredith I
    Adv Ther; 2010 Mar; 27(3):129-41. PubMed ID: 20437213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.